This seizure-spotting smart watch has won FDA approval
Startup Empatica says its Embrace smart watch is now approved by the US Food and Drug Administration as a medical device—a rare designation for a wearable.
Winning approval: The $249 watch detects when a wearer is having a convulsive seizure and lets family members know via a smartphone app. In a 135-patient trial as part of the FDA approval, epilepsy patients suffered 40 seizures, and the watch’s algorithm spotted them all.
Why it matters: There are 3.4 million people in the US with epilepsy. Worldwide, the figure is roughly 50 million. Keeping track of when seizures happen can help get patients medical attention and aid doctors in monitoring their condition over time.
What it means for wearables: The approval allows the firm to make medical claims about the device, and could enable people with epilepsy to have insurance pay for it. It may also encourage doctors and hospitals to use such devices, says Rosalind Picard, Empatica’s cofounder and chief scientist.
Deep Dive
Policy
Is there anything more fascinating than a hidden world?
Some hidden worlds--whether in space, deep in the ocean, or in the form of waves or microbes--remain stubbornly unseen. Here's how technology is being used to reveal them.
What Luddites can teach us about resisting an automated future
Opposing technology isn’t antithetical to progress.
A brief, weird history of brainwashing
L. Ron Hubbard, Operation Midnight Climax, and stochastic terrorism—the race for mind control changed America forever.
Africa’s push to regulate AI starts now
AI is expanding across the continent and new policies are taking shape. But poor digital infrastructure and regulatory bottlenecks could slow adoption.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.